Literature DB >> 167691

Early cytoplasmic vacuolization of African green monkey kidney cells by SV40.

T Miyamura, T Kitahara.   

Abstract

As early as 3--4 hours after infection with SV40 at a high input multiplicity, African green monkey (Cercopithecus aethiops) kidney (AGMK) cells developed cytoplasmic vacuolization. At 10--20 hours after infection, the vacuolization reached its maximal level, then disappeared and SV40 specific cytopathic change followed. This vacuolization developed before the synthesis of the specific T and V antigens. This early cytoplasmic vacuolization (ECV) was prevented by preincubating the virus with specific antiserum, or by heating the virus with MgCl2. The ECV could be induced by UV-irradiated SV40. Addition of metabolic inhibitors had no effect on the induction of the ECV. These results suggest that the capacity to induce the ECV resides in a structural component(s) of SV40 virion and the vacuolization is not associated with the replication of SV40.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167691     DOI: 10.1007/bf01318147

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  [MICROCINEMATOGRAPHIC STUDY OF THE CYTOPATHOGENIC EFFECT OF THE VACUOLIZING (SV 40) VIRUS ON RENAL CELLS OF CERCOPITHECUS AETHIOPS].

Authors:  M PRUNIERAS; Y CHARDONNET; R SOHIER
Journal:  Ann Inst Pasteur (Paris)       Date:  1964-01

2.  SYNTHESIS OF SV40 TUMOR ANTIGEN DURING REPLICATION OF SIMIAN PAPOVAVIRUS (SV40).

Authors:  F RAPP; T KITAHARA; J S BUTEL; J L MELNICK
Journal:  Proc Natl Acad Sci U S A       Date:  1964-11       Impact factor: 11.205

Review 3.  GROWTH CYCLE OF ARBOVIRUSES IN VERTEBRATE AND ARTHROPOD CELLS.

Authors:  M MUSSGAY
Journal:  Prog Med Virol       Date:  1964

4.  Quantitative studies on viral interference in suspended L cells. II. Factors affecting interference by UV-irradiated Newcastle disease virus against vesicular stomatitis virus.

Authors:  K CANTELL; Z SKURSKA; K PAUCKER; W HENLE
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

5.  Studies on simian virus 40.

Authors:  H M MEYER; H E HOPPS; N G ROGERS; B E BROOKS; B C BERNHEIM; W P JONES; A NISALAK; R D DOUGLAS
Journal:  J Immunol       Date:  1962-06       Impact factor: 5.422

6.  Metabolic requirements for infection by Rous sarcoma virus. IV. Virus reproduction and cellular transformation without cellular division.

Authors:  J P Bader
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

7.  Multiplicity reactivation of human adenovirus type 12 and simian virus 40 irradiated by ultraviolet light.

Authors:  H Yamamoto; H Shimojo
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

8.  Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus.

Authors:  A S Huang; R R Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

9.  Growth characteristics of reovirus type 2: ultraviolet light inactivated virion preparations and cell death.

Authors:  P C Loh; H K Oie
Journal:  Arch Gesamte Virusforsch       Date:  1969

10.  Reovirus cytotoxicity: some properties of the UV-irradiated reovirus and its capsid proteins.

Authors:  H A Subasinghe; P C Loh
Journal:  Arch Gesamte Virusforsch       Date:  1972
View more
  3 in total

Review 1.  Cytoplasmic vacuolization in cell death and survival.

Authors:  Andrey V Shubin; Ilya V Demidyuk; Alexey A Komissarov; Lola M Rafieva; Sergey V Kostrov
Journal:  Oncotarget       Date:  2016-08-23

2.  Interaction between Simian Virus 40 Major Capsid Protein VP1 and Cell Surface Ganglioside GM1 Triggers Vacuole Formation.

Authors:  Yong Luo; Nasim Motamedi; Thomas G Magaldi; Gretchen V Gee; Walter J Atwood; Daniel DiMaio
Journal:  MBio       Date:  2016-03-22       Impact factor: 7.867

3.  SV40 Polyomavirus Activates the Ras-MAPK Signaling Pathway for Vacuolization, Cell Death, and Virus Release.

Authors:  Nasim Motamedi; Xaver Sewald; Yong Luo; Walther Mothes; Daniel DiMaio
Journal:  Viruses       Date:  2020-10-05       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.